STAAR Surgical (NASDAQ:STAA) Trading 7.9% Higher

STAAR Surgical is a medical device company that designs and manufactures surgical instruments for various procedures such as eye surgery, neurosurgery, and orthopedic surgery. The company's products are used in hospitals and clinics around the world.

On July 14, 2021, STAAR Surgical reported its second quarter financial results for the period ended June 30, 2021. The company's revenue for the quarter was $57.9 million, which represents a 16% increase compared to the same period in the previous year. Net income for the quarter was $4.8 million, which represents a 20% increase compared to the same period in the previous year.

In addition to its financial performance, STAAR Surgical also announced that its stock price had increased by 7.9% on July 14, 2021. This was due to positive news about the company's products and growth prospects. For example, in May 2021, the company received FDA clearance for its Triton™ Vision System, which is a surgical platform designed for cataract surgery. The system includes a range of instruments and tools that are designed to improve the precision and accuracy of cataract surgery.

Overall, STAAR Surgical's financial performance and growth prospects suggest that the company is well-positioned to continue its success in the medical device industry.